Thus, tumor cells subjected to EMT show a series of molecular changes characterized by decreased expression of epithelial markers, as E-cadherin, ZO-1 and occludin, and increased expression of mesenchymal markers as N-cadherin, vimentin and fibronectin [26]. The gene discussed is CDH2; the disease is neoplasm.